ATRC - Company ID 0001323885
The table below shows AtriCure, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $534.53M | $465.31M | $399.25M | $330.38M | $274.33M | $206.53M |
| Cost of revenue | $133.75M | $117.78M | $98.88M | $84.44M | $68.47M | $57.22M |
| Gross profit | $400.78M | $347.52M | $300.37M | $245.94M | $205.86M | $149.31M |
| R&D | $99.21M | $96.18M | $73.92M | $57.34M | $48.51M | $43.07M |
AtriCure, Inc. reported annual revenue of $534.53M for fiscal year 2025. That is up 14.9% from $465.31M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $155.11M (FY 2016) to $534.53M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $311.02M |
| $291.36M |
| $253.14M |
| $231.27M |
| $204.65M |
| $150.83M |
| Operating income | -$9.45M | -$40.01M | -$26.68M | -$42.67M | $55.20M | -$44.23M |
| Income tax | $1.28M | $1.02M | $591.00K | $268.00K | $188.00K | $114.00K |
| Net income | -$11.45M | -$44.70M | -$30.44M | -$46.47M | $50.20M | -$48.16M |
| EPS (diluted) | -$0.24 | -$0.95 | -$0.66 | -$1.02 | $1.09 | -$1.14 |